MedChem exam content
á Explain terms pharmacodynamics, pharmacokinetics, bioavailability
á Uptake routes for drugs
á Body fluid compartments, volume of distribution
á Drug absorption in the intestinal tract, transport through epithelial cells
á Blood-brain barrier
á Efflux pumps
á Binding to plasma proteins
á Metabolic phase 1 and 2
á Elimination of drugs
á Dosing
á Drug toxicity
á Phases of drug development
á Target identification
á Biophysics of drug-receptor interactions
á Polar surface area
á Binding affinities
á Properties of fragments,leads and drugs
á Lipinski rules
á Screening techniques
á Virtual screening
á Isosters/bioisosters
á QSAR relationsships
á Hansch equation (which terms are included?)
á 3D QSAR
á pharmacophores
á changing solubility
á prodrugs
á drug delivery systems
á fragments-based drug design, SAR-by-NMR
á properties of fragments vs drugs
á rational drug design
á methods (roughly): X-ray,NMR,SPR, Ultracentrifugation, ITC, DSC, Thermafluor
á most important receptors, mode of action, structures (roughly)
á dose-response curves, binding curves, definition of Kd, agonist, antagonist (full and partial, inverse ag.)
á determination of Kd
á antibacterials: strategies, membranes of mammalian, gram +/- cells, action and targets of antibiotics
á antiviral drugs:strategies, HIV/influenza treatments
á anticancer drugs: hallmarks of cancer, mode of action of anti-cancer drugs, antibodies
á anti-inflammatory drugs: immune response, innate and adaptive immune system, pain mediators
MedChem exam content
(part D. Obrecht)
1.
á Drug absorption,
distribution and elimination
á Bioavailability
á AUC
2. Lead
Discovery and Lead Optimization-Drugability
á Drugability parameters
á Shape analysis
á Is there a difference between leads and drugs? the rule of 4
á Fragments: the
rule of 3
á Privileged
structural elements
á Bioisosteres
3. Combinatorial and Parallel
Synthesis in Medicinal Chemistry
á Historical
background-objective
á The role of combinatorial chemistry and parallel synthesis
in drug discovery
á Compound mixtures
versus single compounds
á Solid phase
synthesis versus synthesis in solution
á Parallel versus
split-mixed synthesis
4. Combinatorial
synthesis of Biopolymers
á Linear, modular
synthesis of biopolymers
á Solid-phase
synthesis of polypeptides; peptoids; oligosaccharides
á Parallel synthesis
vs combinatorial synthesis: split-mixed synthesis
á Examples for
solid-phase synthesis: Split-mixed synthesis; tagging strategies; pin synthesis; tea-bags;
photolithography; radiofrequency tags; binary encoding; factor Xa inhibitors; thrombin inhibitors; inhibitors of
protein-protein interactions; hot spots and o-rings;
synthesis of a-helix mimetics; phage libraries;
á Peptide mimetics
á Library synthesis
planning
á Synthesis
strategies
á Classical
multi-component reactions (MCRÕs)
á Sequential
multi-component reactions (SMCRÕs)
á Diversity-oriented
synthesis (DOS)
á Collective
synthesis of natural products
á Fragment-based
lead discovery
á Dynamic
Combinatorial Synthesis;
á Target-guided
synthesis (TGS)
á Disulfide thethering; click chemistry
á Most important reactions used in parallel and
combinatorial synthesis
á Most important building blocks used in parallel and
combinatorial synthesis
á Parallel and/or
combinatorial synthesis
á Parallel work-up